Exercise Training and Type 2 Diabetes
The Effect of Complex Exercise Training on General Health Status in Patients with Type 2 Diabetes
2 other identifiers
interventional
126
1 country
1
Brief Summary
Objective: This study investigates the effects of hybrid training in the form of small-sided football games on health status, blood glucose regulation, muscle metabolism, and well-being in patients with type 2 diabetes mellitus (T2DM), with additional focus on the impact of concurrent treatment with Glucagon-Like Peptide-1 receptor agonists and Sodium-Glucose Co-Transporter-2 inhibitors. Background: T2DM prevalence has surged globally, characterized by insulin resistance, abnormal insulin secretion, and elevated blood glucose levels, significantly increasing cardiovascular disease risk. Physical activity is known to reduce visceral fat, improve glycaemic control, and lower cardiovascular mortality. However, the interaction between hybrid training and T2DM medication effects remains underexplored. Methods: A randomized controlled trial will be conducted with men and women aged 40-70 diagnosed with T2DM within the last 10 years. Exclusion criteria include severe micro- or macrovascular complications and pregnancy. Participants (n=800) will be invited and enrolled participants will be randomized in a 60/40 ratio into a football group (FG) or control group (CG), using a stratified randomization approach. Stratification will be based on age, gender and GLP-1 agonist treatment. The FG will engage in 60-minute small-sided football sessions three times per week for 14 weeks. Both groups will undergo pre- and post-intervention assessments, including blood pressure, blood parameters, body composition via dual-energy X-ray absorptiometry scans, physical fitness (Peak oxygen uptake and Yo-Yo Intermittent Endurance Test Level 1), and 24-hour glucose profiling using Continuous Glucose Monitoring systems. Muscle biopsies will be collected from a subset of participants. Conclusion: This study aims to provide insights into the benefits of hybrid training for T2DM patients, potentially informing new treatment guidelines that integrate exercise and pharmacotherapy to optimize health outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 7, 2024
CompletedFirst Posted
Study publicly available on registry
June 27, 2024
CompletedStudy Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2024
CompletedDecember 24, 2024
December 1, 2024
5 months
June 7, 2024
December 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lean mass (kg)
Lean mass will be measured using Dual-energy X-ray absorptiometry (DXA) scans
Change from baseline to end-of-intervention (14 weeks)
Secondary Outcomes (25)
Fasting plasma glucose (mmol/L)
Change from baseline to end-of-intervention (14 weeks)
Peak oxygen uptake (mL/min)
Change from baseline to end-of-intervention (14 weeks)
Glycosylated hemoglobin A1c (HbA1c) (mmol/mol)
Change from baseline to end-of-intervention (14 weeks)
C-peptide (nmol/L)
Change from baseline to end-of-intervention (14 weeks)
24h glycemic variability
Change from baseline to end-of-intervention (14 weeks)
- +20 more secondary outcomes
Other Outcomes (6)
Systemic markers of inflammation (fg/mL)
Change from baseline to end-of-intervention (14 weeks)
White blood cell count (×10^9/L)
Change from baseline to end-of-intervention (14 weeks)
C-reactive protein (mg/L)
Change from baseline to end-of-intervention (14 weeks)
- +3 more other outcomes
Study Arms (2)
Exercise training
ACTIVE COMPARATORPatients in the exercise group will engage in supervised soccer training 3 times a week for 14 weeks.
Control
NO INTERVENTIONPatients in the control group will receive standard treatment and be instructed to maintain habitual activity levels at the same level as before enrollment in the study.
Interventions
Exercise training will be performed as supervised small sided soccer games (3v3 to 7v7) 3 times a week for 14 weeks. Each session will last \~1 hour. Patients allocated to soccer training will undergo a ramp-up phase consisting of walking soccer training during weeks 1 and 2, after which normal soccer training will be applied from weeks 3 to 14.
Eligibility Criteria
You may qualify if:
- Diagnosed with type 2 diabetes within ten years of study recruitment
You may not qualify if:
- Diabetic retinopathy (expect mild non-proliferative retinopathy or early proliferative retinopathy
- Macro-albuminuria (urine albumin-creatinine ratio ≥ 300 mg/g)
- Nepropathy (plasma creatinine ≥ 130 μM)
- Diabetic neuropathy (except mild affected vibratory testing (\<50 V)
- History of ischemic heart disease
- History or signs of arterial insufficiency
- Steroid treatment within 3 months of baseline examination
- Thyroid disease
- Inability or contraindication to increased levels of physical activity
- Anaemia (haemoglobin \< 7.3 mmol/L (women) and 8.3 mmol/L (men)
- Signs of kidney disease
- Pregnancy or breast feeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of the Faroe Islandslead
- National Hospital of the Faroe Islandscollaborator
- University of Copenhagencollaborator
Study Sites (1)
University of the Faroe Islands
Tórshavn, 110, Faroe Islands
Related Publications (26)
Andersen TR, Schmidt JF, Thomassen M, Hornstrup T, Frandsen U, Randers MB, Hansen PR, Krustrup P, Bangsbo J. A preliminary study: effects of football training on glucose control, body composition, and performance in men with type 2 diabetes. Scand J Med Sci Sports. 2014 Aug;24 Suppl 1:43-56. doi: 10.1111/sms.12259. Epub 2014 Jun 5.
PMID: 24903461BACKGROUNDBalakumar P, Maung-U K, Jagadeesh G. Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res. 2016 Nov;113(Pt A):600-609. doi: 10.1016/j.phrs.2016.09.040. Epub 2016 Sep 30.
PMID: 27697647BACKGROUNDBarbosa A, Brito J, Figueiredo P, Seabra A, Mendes R. Football can tackle type 2 diabetes: a systematic review of the health effects of recreational football practice in individuals with prediabetes and type 2 diabetes. Res Sports Med. 2021 May-Jun;29(3):303-321. doi: 10.1080/15438627.2020.1777417. Epub 2020 Jun 22.
PMID: 32567951BACKGROUNDCho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, Malanda B. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018 Apr;138:271-281. doi: 10.1016/j.diabres.2018.02.023. Epub 2018 Feb 26.
PMID: 29496507BACKGROUNDConnolly LJ, Nordsborg NB, Nyberg M, Weihe P, Krustrup P, Mohr M. Low-volume high-intensity swim training is superior to high-volume low-intensity training in relation to insulin sensitivity and glucose control in inactive middle-aged women. Eur J Appl Physiol. 2016 Oct;116(10):1889-97. doi: 10.1007/s00421-016-3441-8. Epub 2016 Jul 29.
PMID: 27473445BACKGROUNDGBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1659-1724. doi: 10.1016/S0140-6736(16)31679-8.
PMID: 27733284BACKGROUNDGregg EW, Chen H, Wagenknecht LE, Clark JM, Delahanty LM, Bantle J, Pownall HJ, Johnson KC, Safford MM, Kitabchi AE, Pi-Sunyer FX, Wing RR, Bertoni AG; Look AHEAD Research Group. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012 Dec 19;308(23):2489-96. doi: 10.1001/jama.2012.67929.
PMID: 23288372BACKGROUNDJohansen MY, MacDonald CS, Hansen KB, Karstoft K, Christensen R, Pedersen M, Hansen LS, Zacho M, Wedell-Neergaard AS, Nielsen ST, Iepsen UW, Langberg H, Vaag AA, Pedersen BK, Ried-Larsen M. Effect of an Intensive Lifestyle Intervention on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial. JAMA. 2017 Aug 15;318(7):637-646. doi: 10.1001/jama.2017.10169.
PMID: 28810024BACKGROUNDHallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U; Lancet Physical Activity Series Working Group. Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet. 2012 Jul 21;380(9838):247-57. doi: 10.1016/S0140-6736(12)60646-1.
PMID: 22818937BACKGROUNDKrustrup P, Krustrup BR. Football is medicine: it is time for patients to play! Br J Sports Med. 2018 Nov;52(22):1412-1414. doi: 10.1136/bjsports-2018-099377. Epub 2018 Jun 9. No abstract available.
PMID: 29886433BACKGROUNDKrustrup P, Skoradal MB, Randers MB, Weihe P, Uth J, Mortensen J, Mohr M. Broad-spectrum health improvements with one year of soccer training in inactive mildly hypertensive middle-aged women. Scand J Med Sci Sports. 2017 Dec;27(12):1893-1901. doi: 10.1111/sms.12829. Epub 2017 Jan 25.
PMID: 28124381BACKGROUNDMacLeod SF, Terada T, Chahal BS, Boule NG. Exercise lowers postprandial glucose but not fasting glucose in type 2 diabetes: a meta-analysis of studies using continuous glucose monitoring. Diabetes Metab Res Rev. 2013 Nov;29(8):593-603. doi: 10.1002/dmrr.2461.
PMID: 24038928BACKGROUNDMilanovic Z, Pantelic S, Sporis G, Mohr M, Krustrup P. Health-Related Physical Fitness in Healthy Untrained Men: Effects on VO2max, Jump Performance and Flexibility of Soccer and Moderate-Intensity Continuous Running. PLoS One. 2015 Aug 25;10(8):e0135319. doi: 10.1371/journal.pone.0135319. eCollection 2015.
PMID: 26305880BACKGROUNDMohr M, Lindenskov A, Holm PM, Nielsen HP, Mortensen J, Weihe P, Krustrup P. Football training improves cardiovascular health profile in sedentary, premenopausal hypertensive women. Scand J Med Sci Sports. 2014 Aug;24 Suppl 1:36-42. doi: 10.1111/sms.12278.
PMID: 24944131BACKGROUNDNoyes AM, Dua K, Devadoss R, Chhabra L. Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease. World J Diabetes. 2014 Dec 15;5(6):868-76. doi: 10.4239/wjd.v5.i6.868.
PMID: 25512789BACKGROUNDPandey A, Chawla S, Guchhait P. Type-2 diabetes: Current understanding and future perspectives. IUBMB Life. 2015 Jul;67(7):506-13. doi: 10.1002/iub.1396. Epub 2015 Jul 15.
PMID: 26177573BACKGROUNDPedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports. 2006 Feb;16 Suppl 1:3-63. doi: 10.1111/j.1600-0838.2006.00520.x.
PMID: 16451303BACKGROUNDPedersen BK, Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72. doi: 10.1111/sms.12581.
PMID: 26606383BACKGROUNDPedersen MT, Vorup J, Nistrup A, Wikman JM, Alstrom JM, Melcher PS, Pfister GU, Bangsbo J. Effect of team sports and resistance training on physical function, quality of life, and motivation in older adults. Scand J Med Sci Sports. 2017 Aug;27(8):852-864. doi: 10.1111/sms.12823. Epub 2017 Feb 1.
PMID: 28144978BACKGROUNDRedmon JB, Bertoni AG, Connelly S, Feeney PA, Glasser SP, Glick H, Greenway F, Hesson LA, Lawlor MS, Montez M, Montgomery B; Look AHEAD Research Group. Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care. 2010 Jun;33(6):1153-8. doi: 10.2337/dc09-2090. Epub 2010 Mar 23.
PMID: 20332353BACKGROUNDRied-Larsen M, Christensen R, Hansen KB, Johansen MY, Pedersen M, Zacho M, Hansen LS, Kofoed K, Thomsen K, Jensen MS, Nielsen RO, MacDonald C, Langberg H, Vaag AA, Pedersen BK, Karstoft K. Head-to-head comparison of intensive lifestyle intervention (U-TURN) versus conventional multifactorial care in patients with type 2 diabetes: protocol and rationale for an assessor-blinded, parallel group and randomised trial. BMJ Open. 2015 Dec 9;5(12):e009764. doi: 10.1136/bmjopen-2015-009764.
PMID: 26656025BACKGROUNDSargeant JA, Henson J, King JA, Yates T, Khunti K, Davies MJ. A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans. Endocrinol Metab (Seoul). 2019 Sep;34(3):247-262. doi: 10.3803/EnM.2019.34.3.247.
PMID: 31565876BACKGROUNDSkoradal MB, Helge EW, Jorgensen NR, Mortensen J, Weihe P, Krustrup P, Mohr M. Osteogenic impact of football training in 55- to 70-year-old women and men with prediabetes. Scand J Med Sci Sports. 2018 Aug;28 Suppl 1:52-60. doi: 10.1111/sms.13252. Epub 2018 Jul 26.
PMID: 30047579BACKGROUNDSkoradal MB, Weihe P, Patursson P, Mortensen J, Connolly L, Krustrup P, Mohr M. Football training improves metabolic and cardiovascular health status in 55- to 70-year-old women and men with prediabetes. Scand J Med Sci Sports. 2018 Aug;28 Suppl 1:42-51. doi: 10.1111/sms.13081. Epub 2018 May 2.
PMID: 29718556BACKGROUNDVeyhe AS, Andreassen J, Halling J, Grandjean P, Petersen MS, Weihe P. Prevalence of type 2 diabetes and prediabetes in the Faroe Islands. Diabetes Res Clin Pract. 2018 Jun;140:162-173. doi: 10.1016/j.diabres.2018.03.036. Epub 2018 Mar 27.
PMID: 29596941BACKGROUNDZheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018 Feb;14(2):88-98. doi: 10.1038/nrendo.2017.151. Epub 2017 Dec 8.
PMID: 29219149BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The above-mentioned are masked with regards to exercise and control (non-exercise) Statistical analysis of primary outcome will be blinded to the assessor.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 7, 2024
First Posted
June 27, 2024
Study Start
August 1, 2024
Primary Completion
December 20, 2024
Study Completion
December 20, 2024
Last Updated
December 24, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share